HNRNPM expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.343240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.062400E-01
Normal-vs-Stage2
1.195170E-01
Normal-vs-Stage3
1.754430E-01
Normal-vs-Stage4
3.918400E-01
Stage1-vs-Stage2
4.014200E-01
Stage1-vs-Stage3
2.634000E-01
Stage1-vs-Stage4
8.415000E-01
Stage2-vs-Stage3
1.817040E-01
Stage2-vs-Stage4
5.965600E-01
Stage3-vs-Stage4
2.835200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.544030E-01
Normal-vs-AfricanAmerican
3.264600E-01
Normal-vs-Asian
8.350300E-02
Caucasian-vs-AfricanAmerican
6.130400E-01
Caucasian-vs-Asian
5.128200E-01
AfricanAmerican-vs-Asian
3.034800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.556180E-01
Normal-vs-Female
1.268360E-01
Male-vs-Female
8.494600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.415000E-01
Normal-vs-Age(41-60Yrs)
1.261030E-01
Normal-vs-Age(61-80Yrs)
1.271570E-01
Normal-vs-Age(81-100Yrs)
3.234000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.507200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.333200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.674200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.202100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.941000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.461200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.263200E-01
Normal-vs-Daily Drinker
2.326600E-01
Normal-vs-Weekly Drinker
3.437000E-01
Normal-vs-Occasional Drinker
2.703800E-01
Normal-vs-Social Drinker
8.173900E-02
Non Drinker-vs-Daily Drinker
6.666800E-01
Non Drinker-vs-Weekly Drinker
7.130600E-01
Non Drinker-vs-Occasional Drinker
2.411200E-01
Non Drinker-vs-Social Drinker
9.284400E-01
Daily Drinker-vs-Weekly Drinker
9.817600E-01
Daily Drinker-vs-Occasional Drinker
4.843600E-01
Daily Drinker-vs-Social Drinker
5.824400E-01
Weekly Drinker-vs-Occasional Drinker
5.871400E-01
Weekly Drinker-vs-Social Drinker
6.394600E-01
Occasional Drinker-vs-Social Drinker
1.662580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.999000E-01
Normal-vs-Grade 2
9.954600E-01
Normal-vs-Grade 3
9.701200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.309000E-01
Grade 1-vs-Grade 3
5.858400E-01
Grade 1-vs-Grade 4
9.999000E-01
Grade 2-vs-Grade 3
2.806800E-01
Grade 2-vs-Grade 4
9.954600E-01
Grade 3-vs-Grade 4
9.701200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.510200E-01
Normal-vs-NonDiabetic
1.129570E-01
Diabetic-vs-NonDiabetic
7.158000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.604600E-01
Normal-vs-NoPancreatitis
1.806220E-01
Pancreatitis-vs-NoPancreatitis
2.424000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.018800E-01
Normal-vs-N1
1.212620E-01
N0-vs-N1
9.911800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.121200E-01
Normal-vs-TP53-NonMutant
1.854050E-01
TP53-Mutant-vs-TP53-NonMutant
8.488000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
